Continuing Medical Education Information

Jointly sponsored by
The Medical University of South Carolina
and The American Academy of Addiction Psychiatry

1. Participants will be able to describe substance abuse and psychiatric disorders in children and adolescents.

2. Participants will be able to discuss the Clinical Trials Network.

3. Participants will be able to outline the use of topiramate and anticonvulsants for the treatment of alcohol dependence.

4. Participants will be able to describe screening methods, treatment options and outcomes for sexually transmitted diseases and coexisting mental and addictive disorders.

5. Participants will be able to describe pain management as it relates to substance abuse.

1. Participants will be able to identify the clinically-relevant pharmacological characteristics of buprenorphine.

2. Participants should be able to describe the resources needed to set up office-based treatment with buprenorphine for patients with opioid dependence.

3. Participants should be able to describe and contrast the functions of full agonists, partial agonists and antagonists.

4. Participants should be able to list special treatment considerations associated with adolescent opioid-dependent patients and list factors to consider in evaluating a pregnant opioid-dependant woman.

5. Participants should be able to describe symptoms of opioid withdrawal or intoxication that mimic symptoms of a psychiatric disorder.

The Medical University of South Carolina designates this educational activity for a maximum of 26.25 Category 1 credits towards the AMA Physician’s Recognition Award (8 credits for the Optional Pre-Conference Buprenorphine Training and 18.25 credits for the Annual Meeting). Each physician should claim only those credits that he/she actually spent in the educational activity.

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Medical University of South Carolina and the American Academy of Addiction Psychiatry. The Medical University of South Carolina is accredited by the ACCME to provide continuing medical education for physicians.

The Medical University of South Carolina adheres to the Accreditation Council for Continuing Medical Education requirements on disclosure. Information about relationships of presenters with commercial interests will be included in material distributed at the time of the conference.

Disclosure of Discussion of Non-FDA Approved Uses for Pharmaceutical Products and/or Medical Devices

As an ACCME accredited provider of continuing medical education, the Medical University of South Carolina requires that all faculty presenters identify and disclose any "off label" uses for pharmaceutical and medical device products.